4//SEC Filing
Chrousos Phaedra 4
Accession 0000950170-25-083889
CIK 0001347178other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 5:35 PM ET
Size
4.7 KB
Accession
0000950170-25-083889
Insider Transaction Report
Form 4
Chrousos Phaedra
Director
Transactions
- Award
Common Stock
2025-06-05+59,225→ 123,350 total
Footnotes (1)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 5, 2026, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeother
Related Parties
1- filerCIK 0001774518
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 5:35 PM ET
- Size
- 4.7 KB